Approaches to pseudopeptidic ergopeptines. Part 3.1 Consequences of the incorporation of an α-azaphenylalanine residue into the ergotamine oxa-cyclolic system

(Note: The full text of this document is currently only available in the PDF Version )

Anna Calcagni, Gino Lucente, Grazia Luisi, Francesco Pinnen, Domenico Rossi and Enrico Gavuzzo


Abstract

In the context of a research program aimed at synthesizing pseudopeptidic ergopeptines, the incorporation of an α-azaPhe residue into the peptidic moiety of ergotamine has been studied. Acylation of cyclo(-azaPhe-Pro-) 6 with (+)-(S[hair space])-2-benzyloxy-2-methylmalonyl monoethyl ester monochloride 5 gives the (E[hair space])-isoimide 7 as the predominant reaction product; contrary to expectation the conversion of 7 into the desired imide isomer 8 proceeds with difficulty and is accompanied by decomposition. Hydrogenolysis of 8 leads stereospecifically to the pseudopeptidic oxa-cyclol ethyl ester 9. Subsequent rearrangement of the corresponding oxa-cyclol acyl-azide 11 in the presence of benzyl alcohol fails to give the pseudopeptidic ergotamine oxa-cyclol. The new stable pseudopeptidic aza-cyclol 12 containing the residue of the didehydroalanine has been isolated together with a comparable amount of the imino aza-cyclol derivative 13. The mechanism of the formation of the new products 12 and 13 and the unexpected stability of the (E[hair space])-isoimide 7 are discussed.


References

  1. Part 2, F. Pinnen, G. Luisi, A. Calcagni, G. Lucente, E. Gavuzzo and S. Cerrini, J. Chem. Soc., Perkin Trans. 1, 1994, 1611 Search PubMed.
  2. P. A. Stadler and P. Stutz, in The Alkaloids: Chemistry and Physiology, ed. R. H. F. Manske, Academic Press, New York, 1975, vol. 15, p. 1 Search PubMed.
  3. B. Berde and H. P. Veber, Advances in Biochemical Psychopharmacology, eds. E. Costa and P. Greengard, Raven Press, New York, 1980, vol. 23, p. 3 Search PubMed.
  4. R. K. A. Giger, H. R. Loosli, M. D. Walkinshaw, B. J. Clark and J. M. Vigouret, Experientia, 1987, 43, 1125 Search PubMed.
  5. R. A. Hughes and P. R. Andrews, J. Pharm. Pharmacol., 1987, 39, 339 Search PubMed.
  6. F. Pinnen, G. Luisi, G. Lucente, E. Gavuzzo and S. Cerrini, J. Chem. Soc., Perkin Trans. 1, 1993, 819 RSC.
  7. A. Hofmann, A. J. Frey and H. Ott, Experientia, 1961, 17, 206 Search PubMed.
  8. V. I. Minkin and I. E. Mikhailov, in The Chemistry of Amidines and Imidates, eds. S. Patai and Z. Rappoport, John Wiley & Sons Ltd, Chichester, 1991, vol. 2, pp. 527–621 Search PubMed; C. L. Perrin, pp. 206–207.
  9. J. W. Schulenberg and S. Archer, Org. React. (NY), 1965, 14, 31.
  10. D. G. McCarthy and A. F. Hegarty, J. Chem. Soc., Perkin Trans. 2, 1977, 1085 RSC.
  11. A. F. Hegarty and M. T. McCormack, J. Chem. Soc., Chem. Commun., 1975, 168 RSC.
  12. L. M. Weinstock, S. Karady, F. E. Roberts, A. M. Hoinowski, G. S. Brenner, T. B. K. Lee, W. C. Lumma and M. Sletzinger, Tetrahedron Lett., 1975, 46, 3979 CrossRef.
  13. A. Hofmann, H. Ott, R. Griot, P. A. Stadler and A. J. Frey, Helv. Chim. Acta, 1963, 46, 2306 CrossRef.
  14. N. J. Bach, H. E. Boaz, E. C. Kornfeld, C.-J. Chang, H. G. Floss, E. W. Hagaman and H. Wenkert, J. Org. Chem., 1974, 39, 1272 CrossRef CAS.
  15. H. Ott, A. J. Frey and A. Hofmann, Tetrahedron, 1963, 19, 1675 CrossRef CAS.
  16. O. E. Edwards and W. Rank, Can. J. Chem., 1990, 68, 1425 CAS.
  17. A. Calcagni, E. Gavuzzo, G. Lucente, F. Mazza, F. Pinnen, G. Pochetti and D. Rossi, Int. J. Peptide Protein Res., 1991, 37, 167 Search PubMed.
  18. H. Ott, A. Hofmann and A. J. Frey, J. Am. Chem. Soc., 1966, 88, 1251 CrossRef CAS.
  19. P. Deslongchamps, in Stereoelectronic Effects in Organic Chemistry, Pergamon Press, Oxford, 1983, and references therein Search PubMed.
  20. R. E. Valters and W. Flitsch, in Ring-Chain Tautomerism, ed. A. R. Katritzky, Plenum Press, New York, 1985, and references therein Search PubMed.
  21. A. P. K. Orrell and J. D. Wallis, J. Chem. Soc., Perkin Trans. 2, 1984, 227 RSC.
Click here to see how this site uses Cookies. View our privacy policy here.